ML25154A077
| ML25154A077 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 06/03/2025 |
| From: | Bartelme J SHINE Technologies |
| To: | Office of Nuclear Reactor Regulation, Document Control Desk |
| Shared Package | |
| ML25154A076 | List: |
| References | |
| 2025-SMT-0019 | |
| Download: ML25154A077 (1) | |
Text
THIS LETTER CONTAINS PROPRIETARY INFORMATION IN ACCORDANCE WITH 10 CFR 2.390 3400 Innovation Ct.
- Janesville, WI 53546
- 877.512.6554
- info@shinemed.com
- www.SHINEtechnologies.com June 3, 2025 2025-SMT-0019 10 CFR 50.71(b)
U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555 SHINE Technologies, LLC Submittal of Annual Financial Report SHINE Technologies, LLC (SHINE) hereby submits its annual financial report, including certified financial statements, in accordance with the requirements of 10 CFR 50.71(b). provides the annual financial report of Illuminated Holdings, Inc. (Illuminated).
SHINE is a subsidiary of Illuminated. SHINE requests that the NRC withhold Enclosure 1, in its entirety, from public disclosure under 10 CFR 2.390. provides an affidavit supporting the proprietary treatment of the SHINE proprietary information contained in Enclosure 1, pursuant to 10 CFR 2.390. SHINE requests that the NRC withhold Enclosure 1, in its entirety, from public disclosure under 10 CFR 2.390. Upon removal of Enclosure 1, this letter is uncontrolled.
If you have any questions, please contact me at 608/210-1735.
I declare under the penalty of perjury that the foregoing is true and correct.
Executed on June 3, 2025.
Very truly yours, Jeff Bartelme Senior Director of Regulatory Affairs SHINE Technologies, LLC Docket No. 50-608 cc:
Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health (w/o Enclosure 1)